GET FREE CONSULTATION!
+256 704 292188
Ghana has granted full national licensure to the R21/Matrix-M™ malaria vaccine, developed by the University of Oxford and manufactured and scaled up by the Serum Institute of India (SII). According to the WHO’s 2022 world malaria report, the disease killed 619,000 people in 2021 – with 96% of those deaths in the WHO African region,…
A UK biotech company has announced £13m of investment that they believe will fund them through to clinical trials next year of the world’s first treatment for a rare, incurable and deadly disease. The investment has been raised by Oxfordshire-based SynaptixBio, whose aim is to tackle TUBB4a leukodystrophy – a genetic and debilitating condition that mainly…
A technique that identifies the build-up of abnormal protein deposits linked to Parkinson’s disease could aid in early detection and play a key role in the disease’s clinical diagnosis and characterisation, according to research published in The Lancet Neurology journal. Findings from the study confirm the technique – known as α-synuclein seed amplification assay (αSyn-SAA)…